1.Analysis on critical value situation in hematology laboratory of a hospital during 2 0 1 5
International Journal of Laboratory Medicine 2017;38(3):358-359
Objective To analyze the critical value items of hematology laboratory during 2015 in order to further perfect the critical values reporting system.Methods The critical value items of hematology laboratory during 2015 were collected from the Laboratory Information System (LIS)of this hospital and perform the statistical analysis on the occurrence rate of critical value,de-partment distribution and specimen source.Results The critical value items included 8 items of RBC,WBC,PLT,etc.There were 9 235 cases of critical value report in 2015 with the incidence rate of 1.74%.PLT had the largest proportion of critical values cases (30.62%),followed by PT (22.27%);PT had the highest rate of critical value(7.27%),followed by PLT(2.67%).The depart-ment of the highest occurrence rate in critical value was the hematology department,followed by the oncology department.Conclu-sion Some problems are exist reporting system,certain problems exist in setting the hematological critical item and threshold value setting .Various laboratories should formulate the critical value limit suitable for the hospital by positively consulting with clinic un-der the basis the setting of critical value items and critical limits.Laboratories should actively consult with clinicians to formulate the critical value limit that is suitable for the hospitals on the basis of reference literatures at home and abroad.
2.Legal Procedure of the Entry of Drug Manufacture in China and USA:A Comparative Study
China Pharmacy 2007;0(25):-
OBJECTIVE: To put forward suggestions for perfecting the Chinese legal procedure of the entry of drug manufacture.METHODS: The defects existing in Chinese legal procedure for the entry of pharmaceutical industry were analyzed by comparing the legal procedure for establishing pharmaceutical enterprise,permission of drug manufacturing and marketing between China and USA.RESULTS & CONCLUSIONS: The Chinese legislature should draw useful legal experiences from USA to amend the legislation defects,substitute the approval procedure of drug manufacturing licence with the procedure of enterprise registration to implement the GMP certification for special drug product,and merge the validation procedure of GMP certification and the review procedure of the pharmaceutical development program and industry policies into the procedure of drug registration and approval.
3.Effect of Irbesartan on Heart Remodelling in Patients with Rheumatic Heart Disease after Valve Surgery
China Pharmacy 2001;0(08):-
OBJECTIVE:To evaluate the effects of Irbesartan on cardiac size and its function in patients with rheumatic heart disease (RHD) after valve surgery.METHODS:50 RHD patients were divided into 2 groups:control group and Irbesartan group.Both groups were given conventional therapy for 6 months.Irbesartan group were additionally treated with Irbesartan (75~150 mg?d-1).Ehocardio graphic examinations were performed before and at 6th month after surgery.RESULTS:As compared with before treatment,the atriums and ventricles volume of 2 groups were decreased significantly at 6th month after treatment.The level of LVEF,RVEF,CI of patients were increased significantly after treatment (P
4.Consideration and discussion on extinction of influenza B/Yamagata virus and switch of vaccine strain
Chinese Journal of Biologicals 2024;37(8):1014-1019
Influenza B/Yamagata has been circulating in humans for nearly half a century as a seasonal influenza virus. Like other subtypes or lineages of influenza viruses,B/Yamagata lineage virus has continuously mutated and evolved,resulting in multiple clades. In 2014,World Health Organization(WHO)recommended B/Phuket/3073/2013,a representative virus of B/Yamagata lineage 3A group,as a candidate vaccine virus. Since then,the 3A group virus had been the predominant virus of B/Yamagata lineage. Since March 2020,no B/Yamagata lineage virus has been isolated globally. B/Yamagata lineage virus has been probably extinct. Recently,there is a suggestion that WHO should exclude B/Yamagata component from quadrivalent influenza vaccines. This paper reviews the development history of influenza B and its vaccine strains,objectively analyzes the possible causes of the disappearance of B/Yamagata lineage viruses,and comprehensively describes the perspectives of multiple disciplines and departments,including virology,epidemiology,immunology,social sciences related to vaccine immunization and vaccine manufacturers. It makes recommendations on preventing the recurrence of B/Yamagata lineage viruses,and also suggests that policy making authorities and vaccine manufacturers should make plans and preparations for the replacement of quadrivalent vaccine to trivalent vaccine.
5.Cost-effectiveness Analysis on Piperacillin/ Tazobactam and Cefoperazone/ Sulbactam in the Treatment of Bacterial Infection of Respiratory Tracts
China Pharmacy 1991;0(05):-
0.05);The cost-effectiveness ratios were 2.29 and 1.84, respectively;The incremental cost-effectiveness ratio of the control group as against the trial group was 18.48. CONCLUSION: The therapy of piperacillin/tazobactam has marked pharmacoeconomics advantage over cefoperazone/sulbactam in treating bacterial infection of respiratory tracts.
6.Discussion on the Transnational R&D Strategy of Chinese Pharmaceutical Enterprises
China Pharmacy 1991;0(06):-
OBJECTIVE:To discuss the transnational R&D strategy of Chinese pharmaceutical enterprises.METHODS:To compare and analyse the R&D status of the pharmaceutical enterprises in China and developed countries.To predicate the difficulties of the transnational R&D strategy.RESULTS &CONCLUSION:It is very possible to carry out the transnational R&D strategy for Chinese pharmaceutical enterprises.They can realize the transnational R&D activity by FDI and M&A,and choose Hongkong as the first location for this strategy.
7.Study on Family Function of Children with Cerebral Palsy
Chinese Journal of Rehabilitation Theory and Practice 2016;22(8):985-988
Objective To analyze the type of family function of children with cerebral palsy. Methods The data collected from 206 valid questionnaires were analyzed. Results The Total Function dimension was as the characteristic value in the family function. The result showed that children's family function could be divided into three types, namely, Problem Solving (M=26.5402), Effective Communication (M=23.4719) and Emotional Intervention (M=33.3750). Problem Solving (47.28%) and Effective Communication (48.37%) were the main types. Conclusion Family function of children with cerebral palsy can be mainly divided into Problem Solving and Effective Communica-tion, less of Emotional Intervention.
8.Social-economic Status and Developmental Needs of People with Intellectual Disability in Henan Province, China
Chinese Journal of Rehabilitation Theory and Practice 2016;22(4):389-394
Objective To understand the basic situation of persons with intellectual disability in Henan province, and to provide relevant support to promote the realization of a well-off society. Methods According to the results of national disabled basic service condition and de-mand special survey, we investigated and analyzed 53,620 people who registered with intellectual disabilities. Results Intellectual disability accounted for 8.60%of the disabled, the average age was about 36.6 years old, men accounted for 61.3%, and women accounted for 38.7%. The average per capita income, education level and employment rate of the persons in Henan province were generally low. Most people en-joyed the medical insurance (94.5%) and medical insurance subsidies (59.1%). The demand for development of the people was mainly re-flected in the special educational, practical technical training, medical rehabilitation, functional training and the non-barrier transformation for kitchen and toilets. Conclusion The rehabilitation medical services in Henan province remain to be improved. The demands of intellectu-al disabilities' multi-level development need more attention.
9.Research progress of fatty acid synthase in cancer
Cancer Research and Clinic 2015;27(10):717-720
Fatty acid synthase (FAS) can be regarded as a tumor-specific therapeutic target.High expression of FAS is found in many tumor tissues, and inhibition of its expression can induce tumor cell death.Recent researches has shown that FAS can be used not only as the target of tumor therapy, but also as a tumor marker.The serum FAS is higher in cancer patients.High expression of FAS is associated with tumor treatment tolerance, and some new inhibitors for FAS show good anti-cancer effects.
10.Research progress in the mechanism of Escherichia coli K1 translocation of the blood-brain barrier
International Journal of Pediatrics 2015;42(2):170-172
Neonatal purulent meningitis is one of the severe infectious diseases of the central nervous system.Escherichia coli K1 (E.coli K1) strain is the most common Gram-negative bacteria which leads to neonatal purulent meningitis.The mechanism of E.coli K1 translocation of the blood-brain barrier(BBB) include the high degree of bacteremia,invasion of brain microvessel endothelia cell by E.coli K1,receptor-mediated pinocytosis transport for E.coli K1 and the living bacteria across the BBB.The current knowledge on the mechanisms underlying the successful E.coli K1 translocation of the BBB are summarized in this review.